PMC:7128678 / 1164-1395 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"56","span":{"begin":108,"end":118},"obj":"Species"},{"id":"63","span":{"begin":38,"end":49},"obj":"Chemical"},{"id":"64","span":{"begin":136,"end":148},"obj":"Chemical"},{"id":"65","span":{"begin":153,"end":165},"obj":"Chemical"},{"id":"66","span":{"begin":200,"end":211},"obj":"Chemical"}],"attributes":[{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"Tax:2697049"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D002738"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D012794"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D005732"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D005732"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ng approaches, this study showed that chloroquine (CLQ), one of the drugs currently under investigation for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of ganglioside-binding domain at t"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T36","span":{"begin":38,"end":49},"obj":"CHEBI:3638;DG_10;CHEBI:3638"},{"id":"T37","span":{"begin":68,"end":73},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T38","span":{"begin":108,"end":118},"obj":"SP_7"},{"id":"T39","span":{"begin":136,"end":148},"obj":"CHEBI:26667;CHEBI:26667"},{"id":"T40","span":{"begin":153,"end":165},"obj":"CHEBI:5386;CHEBI:5386"},{"id":"T41","span":{"begin":200,"end":211},"obj":"CHEBI:28892;CHEBI:28892"},{"id":"T42","span":{"begin":220,"end":226},"obj":"SO:0000417"}],"text":"ng approaches, this study showed that chloroquine (CLQ), one of the drugs currently under investigation for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of ganglioside-binding domain at t"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T7","span":{"begin":153,"end":165},"obj":"Body_part"},{"id":"T8","span":{"begin":200,"end":211},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma82816"},{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma82816"}],"text":"ng approaches, this study showed that chloroquine (CLQ), one of the drugs currently under investigation for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of ganglioside-binding domain at t"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":108,"end":116},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ng approaches, this study showed that chloroquine (CLQ), one of the drugs currently under investigation for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of ganglioside-binding domain at t"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":186,"end":187},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ng approaches, this study showed that chloroquine (CLQ), one of the drugs currently under investigation for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of ganglioside-binding domain at t"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T14","span":{"begin":38,"end":49},"obj":"Chemical"},{"id":"T15","span":{"begin":68,"end":73},"obj":"Chemical"},{"id":"T16","span":{"begin":136,"end":148},"obj":"Chemical"},{"id":"T17","span":{"begin":143,"end":148},"obj":"Chemical"},{"id":"T18","span":{"begin":153,"end":165},"obj":"Chemical"},{"id":"T19","span":{"begin":200,"end":211},"obj":"Chemical"}],"attributes":[{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_26667"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"}],"text":"ng approaches, this study showed that chloroquine (CLQ), one of the drugs currently under investigation for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of ganglioside-binding domain at t"}